| 1 | [SID24813852] | Active | IC50 | 2.957 | Dose Response confirmation of uHTS hits for Scp-1 phosphatase using a colorimetric assay [AID540297, Type: confirmatory] | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | IC50 | 2.957 [uM] | | BioAssay | Dose Response confirmation of uHTS hits for Scp-1 phosphatase using a colorimetric assay | | AID | 540297 | | BioAssay type | confirmatory | | Target | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] | | PubMed | | | Data Table |  |
|
| 2 | [SID24813852] | Active | Potency | 6.3096 | Inhibitors of DNA Polymerase Beta: Hit validation [AID540280, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | Inhibitors of DNA Polymerase Beta: Hit validation | | AID | 540280 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 3 | [SID24813852] | Active | Potency | 6.3096 | Inhibitors of DNA Polymerase Beta: Hit validation [AID540280, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | Inhibitors of DNA Polymerase Beta: Hit validation | | AID | 540280 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 4 | [SID24813852] | Active | Potency | 6.3096 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 5 | [SID24813852] | Active | Potency | 6.3096 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 6 | [SID24813852] | Active | IC50 | 7.6 | Dose response confirmation of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID602386, Type: confirmatory] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | IC50 | 7.6 [uM] | | BioAssay | Dose response confirmation of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 602386 | | BioAssay type | confirmatory | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 7 | [SID24813852] | Active | IC50 | 7.6 | Dose response confirmation of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID602386, Type: confirmatory] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | IC50 | 7.6 [uM] | | BioAssay | Dose response confirmation of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 602386 | | BioAssay type | confirmatory | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 8 | [SID24813852] | Active | Potency | 9.285 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | Potency | 9.285 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID24813852] | Active | IC50 | 9.31 | Dose Response confirmation of small molecule APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay [AID504719, Type: confirmatory] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | IC50 | 9.31 [uM] | | BioAssay | Dose Response confirmation of small molecule APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay | | AID | 504719 | | BioAssay type | confirmatory | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 10 | [SID24813852] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 11 | [SID24813852] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 12 | [SID24813852] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide [AID1768, Type: confirmatory] | MEN1 gene product [Homo sapiens] [gi:18860839] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide | | AID | 1768 | | BioAssay type | confirmatory | | Target | MEN1 gene product [Homo sapiens] [gi:18860839] | | PubMed | | | Data Table |  |
|
| 13 | [SID24813852] | Active | Potency | 17.7828 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 14 | [SID24813852] | Active | Potency | 17.7828 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 15 | [SID24813852] | Active | IC50 | 19.5 | Dose response confirmation of uHTS RPN11 inhibitor hits in a Fluorescence Polarization assay [AID602368, Type: confirmatory] | PSMD14 protein [Homo sapiens] [gi:16306916] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | IC50 | 19.5 [uM] | | BioAssay | Dose response confirmation of uHTS RPN11 inhibitor hits in a Fluorescence Polarization assay | | AID | 602368 | | BioAssay type | confirmatory | | Target | PSMD14 protein [Homo sapiens] [gi:16306916] | | PubMed | | | Data Table |  |
|
| 16 | [SID24813852] | Active | Potency | 20.4339 | qHTS Assay for Inhibitors of GCN5L2: Hit confirmation [AID588347, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | Potency | 20.4339 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2: Hit confirmation | | AID | 588347 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 17 | [SID24813852] | Active | Potency | 20.4339 | qHTS Assay for Inhibitors of GCN5L2: Hit confirmation [AID588347, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | Potency | 20.4339 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2: Hit confirmation | | AID | 588347 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 18 | [SID24813852] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) [AID2549, Type: confirmatory] | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) | | AID | 2549 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] | | PubMed | | | Data Table |  |
|
| 19 | [SID24813852] | Active | Potency | 39.8107 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 20 | [SID24813852] | Active | Potency | 39.8107 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 21 | [SID24813852] | Active | Potency | 44.6684 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 22 | [SID24813852] | Active | Potency | 44.6684 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 23 | [SID24813852] | Active | IC50 | 49.3 | Dose Response confirmation of APOBEC3G DNA Deaminase Inhibitors via a A3A counterscreen [AID504722, Type: confirmatory] | APOBEC3A gene product [Homo sapiens] [gi:21955158] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | IC50 | 49.3 [uM] | | BioAssay | Dose Response confirmation of APOBEC3G DNA Deaminase Inhibitors via a A3A counterscreen | | AID | 504722 | | BioAssay type | confirmatory | | Target | APOBEC3A gene product [Homo sapiens] [gi:21955158] | | PubMed | | | Data Table |  |
|
| 24 | [SID24813852] | Active | IC50 | 50.5 | Dose Response validation of uHTS RPN11 inhibitor hits using a Thrombin Fluorescence Polarization assay [AID602369, Type: confirmatory] | prothrombin [Bos taurus] [gi:296479639] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | IC50 | 50.5 [uM] | | BioAssay | Dose Response validation of uHTS RPN11 inhibitor hits using a Thrombin Fluorescence Polarization assay | | AID | 602369 | | BioAssay type | confirmatory | | Target | prothrombin [Bos taurus] [gi:296479639] | | PubMed | | | Data Table |  |
|
| 25 | [SID24813852] | Active | IC50 | 50.5 | Dose Response validation of uHTS RPN11 inhibitor hits using a Thrombin Fluorescence Polarization assay [AID602369, Type: confirmatory] | prothrombin [Bos taurus] [gi:296479639] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | IC50 | 50.5 [uM] | | BioAssay | Dose Response validation of uHTS RPN11 inhibitor hits using a Thrombin Fluorescence Polarization assay | | AID | 602369 | | BioAssay type | confirmatory | | Target | prothrombin [Bos taurus] [gi:296479639] | | PubMed | | | Data Table |  |
|
| 26 | [SID24813852] | Active | Potency | 56.2341 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | Potency | 56.2341 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 27 | [SID24813852] | Active | Potency | 79.4328 | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). [AID588795, Type: confirmatory] | flap endonuclease 1 [Homo sapiens] [gi:4758356] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). | | AID | 588795 | | BioAssay type | confirmatory | | Target | flap endonuclease 1 [Homo sapiens] [gi:4758356] | | PubMed | | | Data Table |  |
|
| 28 | [SID24813852] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 29 | [SID24813852] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 30 | [SID24813852] | Active | Potency | | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) [AID652105, Type: confirmatory] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) | | AID | 652105 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID24813852] | Active | | | TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization [AID1899, Type: screening] | core protein [Hepatitis C virus] [gi:83779224] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | BioAssay | TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization | | AID | 1899 | | BioAssay type | screening | | Target | core protein [Hepatitis C virus] [gi:83779224] | | PubMed | | | Data Table |  |
|
| 32 | [SID24813852] | Active | | | 384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC [AID463187, Type: screening] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | BioAssay | 384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC | | AID | 463187 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID24813852] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 34 | [SID24813852] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 35 | [SID24813852] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 36 | [SID24813852] | Active | | | uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay [AID651999, Type: screening] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay | | AID | 651999 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID24813852] | Active | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID686964, Type: screening] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide | | AID | 686964 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID24813852] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504904, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504904 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 39 | [SID24813852] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504904, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504904 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 40 | [SID24813852] | Active | IC50 | | uHTS HTRF assay for identification of inhibitors of SUMOylation [AID2006, Type: confirmatory] | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | IC50 | [uM] | | BioAssay | uHTS HTRF assay for identification of inhibitors of SUMOylation | | AID | 2006 | | BioAssay type | confirmatory | | Target | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] | | PubMed | | | Data Table |  |
|
| 41 | [SID24813852] | Active | IC50 | | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H) [AID2012, Type: confirmatory] | Eukaryotic translation initiation factor 4H [Homo sapiens] [gi:45219878] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | IC50 | [uM] | | BioAssay | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H) | | AID | 2012 | | BioAssay type | confirmatory | | Target | Eukaryotic translation initiation factor 4H [Homo sapiens] [gi:45219878] | | PubMed | | | Data Table |  |
|
| 42 | [SID24813852] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504905, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504905 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 43 | [SID24813852] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504905, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504905 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 44 | [SID24813852] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504905, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504905 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 45 | [SID24813852] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 46 | [SID24813852] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 47 | [SID24813852] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 48 | [SID24813852] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 49 | [SID24813852] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 50 | [SID24813852] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 24813852 | | CID | 16194171 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|